Showing results (621-630 of 662) with videos related to

Sort By:
Pageof 67
Metabolic Brain Disease|March 28, 2020
The therapeutic potential of bilobalide on experimental autoimmune encephalomyelitis (EAE) miceQiang Miao, Xiao-Xue Zhang, Qing-Xian Han, et al.
Molecular Neurobiology|September 4, 2016
Fasudil Enhances Therapeutic Efficacy of Neural Stem Cells in the Mouse Model of MPTP-Induced Parkinson's DiseaseYan-Hua Li, Jing-Wen Yu, Jian-Yin Xi, et al.
Advanced Materials (Deerfield Beach, Fla.)|November 6, 2025
Cost-Effective Passive Ammonia Fuel Cells via Synergistic Integration of Optimized Membrane Electrode Assembly and PrototypeXin Ou-Yang, Jun-Yu Wu, Zhao-Hui Wang, et al.
International Journal of Immunopathology and Pharmacology|December 5, 2015
Safflower Yellow regulates microglial polarization and inhibits inflammatory response in LPS-stimulated Bv2 cellsXing-Wang Yang, Yan-Hua Li, Hui Zhang, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|December 19, 2012
[Establishment and evaluation of animal model for studying the effect of traumatic brain injury on bone fracture healing]Xu hong Chen, Lu Bai, Hang-yu Gu, et al.
Journal of Molecular Neuroscience : MN|August 31, 2016
Synergistic and Superimposed Effect of Bone Marrow-Derived Mesenchymal Stem Cells Combined with Fasudil in Experimental Autoimmune EncephalomyelitisJing-Wen Yu, Yan-Hua Li, Guo-Bin Song, et al.
Zoological Research|June 17, 2020
Observation of mother-perpetrated infanticide in golden takins ( Budorcas taxicolor bedfordi)Hai-Tao Zhao, Wen-Qing Zhang, Kang-Sheng Jia, et al.
Bioscience Reports|July 31, 2015
FSD-C10: A more promising novel ROCK inhibitor than Fasudil for treatment of CNS autoimmunityYan-Le Xin, Jie-Zhong Yu, Xin-Wang Yang, et al.
Frontiers in Neurology|February 27, 2023
Natural course and risk factors of moyamoya disease with unruptured intracranial aneurysmRi-Miao Yang, Fang-Bin Hao, Bo Zhao, et al.
Journal of Neurosurgery|May 10, 2024
Development and validation of a novel nomogram for predicting long-term rebleeding risk among patients with hemorrhagic moyamoya disease: a 10-year multicenter retrospective cohort studyJing-Jie Li, Xiao-Peng Wang, Xiang-Yang Bao, et al.
Pageof 67